Literature DB >> 17644037

Influence of calcium channel blocker drugs in neuromuscular transmission.

Yasar Ozkul1.   

Abstract

OBJECTIVE: Calcium channel blockers are commonly used in some cardiovascular disorders. These drugs can act at neuromuscular transmission, at both pre- and postsynaptic levels and may produce neuromuscular dysfunction. Therefore, they may result in misdiagnosis in electrophysiological testing of healthy subjects. This study aimed to investigate the influence of calcium channel blockers on neuromuscular transmission, using single fiber electromyography, in subjects who were healthy excepting controlled arterial hypertension condition.
METHODS: Single fiber electromyography during voluntary contraction of the extensor digitorum communis muscle, nerve conduction studies of upper and lower extremities, and concentric needle electromyography of the extensor digitorum communis were performed on 16 verapamil users, 16 amlodipine users, and 16 age-matched normal controls. Twenty potential pairs were recorded from each subject. Twenty individual jitter values and a mean jitter value were calculated for each subject. Both mean jitter values and numbers of abnormal individual jitter values were compared in verapamil and amlodipine users versus normal controls.
RESULTS: Eight of 16 verapamil users and 7 of amlodipine users showed evident neuromuscular transmission abnormalities by single fiber electromyography. Two subjects from verapamil and one subjects from amlodipine users group had borderline dysfunction of neuromuscular transmission.
CONCLUSIONS: These results suggest that both verapamil and amlodipine impair neuromuscular transmission in subjects without neuromuscular disease. SIGNIFICANCE: The effects of verapamil and amlodipine are at a level, which may cause misinterpretation of single fiber electromyography studies carried out to investigate neuromuscular junction disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644037     DOI: 10.1016/j.clinph.2007.06.002

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  6 in total

1.  Remifentanil does not inhibit sugammadex reversal after rocuronium-induced neuromuscular block in the isolated hemidiaphragm of the rat: an ex vivo study.

Authors:  Jae Moon Choi; Ha-Jung Kim; Hey Ran Choi; Yong Beom Kim; Hyeun Joon Bae; Hong Seuk Yang
Journal:  J Anesth       Date:  2019-09-18       Impact factor: 2.078

Review 2.  Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness.

Authors:  Sirunya Silapunt; Leon Chen; Michael R Migden
Journal:  Ther Adv Med Oncol       Date:  2016-06-29       Impact factor: 8.168

3.  Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study.

Authors:  T A Ashfield; H E Syddall; H J Martin; E M Dennison; C Cooper; A Aihie Sayer
Journal:  Age Ageing       Date:  2009-12-17       Impact factor: 10.668

4.  Antihypertensive and Statin Medication Use and Motor Function in Community-Dwelling Older Adults.

Authors:  Amichai Perlman; Raj C Shah; David A Bennett; Aron S Buchman; Ilan Matok
Journal:  J Am Med Dir Assoc       Date:  2015-11-17       Impact factor: 4.669

5.  Comparison of neuromuscular blockade recovery co-administered with neostigmine and different doses of calcium gluconate: a randomized control trial.

Authors:  So Ron Choi; Jeong Ho Kim; Kyung Hyun Lee; Sang Yoong Park
Journal:  BMC Anesthesiol       Date:  2021-03-29       Impact factor: 2.217

6.  Concentric needle jitter: Reference values in stimulated Tibialis Anterior muscle.

Authors:  João Aris Kouyoumdjian; Carla Renata Graca
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.